Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (401-410 of 588) with videos related to

Pageof 59
Sort By:
Journal of Diabetes Investigation|April 1, 2020
Greater macrovascular and microvascular morbidity from type 2 diabetes in northern compared with southern China: A cross-sectional studyLi Wang, Ying Xing, Xinwen Yu, et al.
Journal of Diabetes and Its Complications|January 30, 2015
Dietary patterns associated with HbA1c and LDL cholesterol among individuals with type 1 diabetes in ChinaLindsay M Jaacks, Jamie Crandell, Michelle A Mendez, et al.
Journal of Diabetes Investigation|June 5, 2019
Evaluation of effectiveness of treatment paradigm for newly diagnosed type 2 diabetes patients in Chin: A nationwide prospective cohort studyXiaoling Cai, Dayi Hu, Changyu Pan, et al.
The Lancet. Diabetes & Endocrinology|June 7, 2025
Once‑weekly IcoSema versus once‑weekly insulin icodec in type 2 diabetes management (COMBINE 1): an open‑label, multicentre, treat‑to‑target, randomised, phase 3a trialChantal Mathieu, Francesco Giorgino, Sin Gon Kim, et al.
Journal of Diabetes|May 29, 2021
Urinary C-peptide/creatinine ratio: A useful biomarker of insulin resistance and refined classification of type 2 diabetes mellitusYanai Wang, Xiantong Zou, Xiaoling Cai, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2024
A Randomized Clinical Trial for Meal Bolus Decision Using Learning-based Control in Adults With Type 2 DiabetesWei Liu, Deheng Cai, Rui Zhang, et al.
Diabetes Care|June 18, 2020
Diabetes and COVID-19: Risks, Management, and Learnings From Other National DisastersJamie Hartmann-Boyce, Elizabeth Morris, Clare Goyder, et al.
Advances in Therapy|May 30, 2026
Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi ConsensusYehuda Handelsman, Alice Y Y Cheng, Gian Paolo Fadini, et al.
Journal of Affective Disorders|August 14, 2013
Measuring depressive symptoms using the Patient Health Questionnaire-9 in Hong Kong Chinese subjects with type 2 diabetesYuying Zhang, Rose Ting, Marco Lam, et al.
Scientific Reports|February 13, 2025
Clinical characteristics and unique presentations of immune checkpoint inhibitor induced type 1 diabetes in Chinese patients from a single institutionWei Liu, Chunmei Li, Yayu Fang, et al.
Pageof 59

Showing results (401-410 of 588) with videos related to

Sort By:
Pageof 59
Journal of Diabetes Investigation|April 1, 2020
Greater macrovascular and microvascular morbidity from type 2 diabetes in northern compared with southern China: A cross-sectional studyLi Wang, Ying Xing, Xinwen Yu, et al.
Journal of Diabetes and Its Complications|January 30, 2015
Dietary patterns associated with HbA1c and LDL cholesterol among individuals with type 1 diabetes in ChinaLindsay M Jaacks, Jamie Crandell, Michelle A Mendez, et al.
Journal of Diabetes Investigation|June 5, 2019
Evaluation of effectiveness of treatment paradigm for newly diagnosed type 2 diabetes patients in Chin: A nationwide prospective cohort studyXiaoling Cai, Dayi Hu, Changyu Pan, et al.
The Lancet. Diabetes & Endocrinology|June 7, 2025
Once‑weekly IcoSema versus once‑weekly insulin icodec in type 2 diabetes management (COMBINE 1): an open‑label, multicentre, treat‑to‑target, randomised, phase 3a trialChantal Mathieu, Francesco Giorgino, Sin Gon Kim, et al.
Journal of Diabetes|May 29, 2021
Urinary C-peptide/creatinine ratio: A useful biomarker of insulin resistance and refined classification of type 2 diabetes mellitusYanai Wang, Xiantong Zou, Xiaoling Cai, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2024
A Randomized Clinical Trial for Meal Bolus Decision Using Learning-based Control in Adults With Type 2 DiabetesWei Liu, Deheng Cai, Rui Zhang, et al.
Diabetes Care|June 18, 2020
Diabetes and COVID-19: Risks, Management, and Learnings From Other National DisastersJamie Hartmann-Boyce, Elizabeth Morris, Clare Goyder, et al.
Advances in Therapy|May 30, 2026
Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi ConsensusYehuda Handelsman, Alice Y Y Cheng, Gian Paolo Fadini, et al.
Journal of Affective Disorders|August 14, 2013
Measuring depressive symptoms using the Patient Health Questionnaire-9 in Hong Kong Chinese subjects with type 2 diabetesYuying Zhang, Rose Ting, Marco Lam, et al.
Scientific Reports|February 13, 2025
Clinical characteristics and unique presentations of immune checkpoint inhibitor induced type 1 diabetes in Chinese patients from a single institutionWei Liu, Chunmei Li, Yayu Fang, et al.
Pageof 59